Skip to content
10-Q

Quarterly Report

REGENERON PHARMACEUTICALS, INC. REGN

0000872589-25-000028

← back to feed
Filed
Oct 28, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q3 2025 · Sep 30, 2025 107.2M sh
Shares Diluted Q3 2025 · Sep 30, 2025 108.9M sh
Shares Diluted Q3 2025 · Sep 30, 2024 116.2M sh
Shares Diluted Q3 2025 · Sep 30, 2024 115.6M sh
Stock Repurchased Q3 2025 · Sep 30, 2025 $2.77B
Stock Repurchased Q3 2025 · Sep 30, 2024 $1.63B
Dividends Paid Q3 2025 · Sep 30, 2025 $277.6M
Dividends Paid Q3 2025 · Sep 30, 2024 $0
Capex Q3 2025 · Sep 30, 2025 $649.7M
Capex Q3 2025 · Sep 30, 2024 $556.3M
Operating Cash Flow Q3 2025 · Sep 30, 2025 $3.81B
Operating Cash Flow Q3 2025 · Sep 30, 2024 $3.16B
Long Term Debt Q3 2025 · Sep 30, 2025 $1.99B
Long Term Debt Q3 2025 · Dec 31, 2024 $1.98B
Cash And Equivalents Q3 2025 · Sep 30, 2025 $2.51B
Cash And Equivalents Q3 2025 · Dec 31, 2024 $2.49B
Cash And Equivalents Q3 2025 · Sep 30, 2024 $2.01B
Stockholders Equity Q3 2025 · Sep 30, 2025 $30.96B
Stockholders Equity Q3 2025 · Jun 30, 2025 $29.94B
Stockholders Equity Q3 2025 · Mar 31, 2025 $29.39B
Stockholders Equity Q3 2025 · Dec 31, 2024 $29.35B
Stockholders Equity Q3 2025 · Sep 30, 2024 $29.33B
Stockholders Equity Q3 2025 · Jun 30, 2024 $28.21B
Stockholders Equity Q3 2025 · Mar 31, 2024 $26.99B
Stockholders Equity Q3 2025 · Dec 31, 2023 $25.97B
Current Liabilities Q3 2025 · Sep 30, 2025 $4.43B
Current Liabilities Q3 2025 · Dec 31, 2024 $3.94B
Total Liabilities Q3 2025 · Sep 30, 2025 $9.21B
Total Liabilities Q3 2025 · Dec 31, 2024 $8.41B
Current Assets Q3 2025 · Sep 30, 2025 $17.98B
Current Assets Q3 2025 · Dec 31, 2024 $18.66B
Total Assets Q3 2025 · Sep 30, 2025 $40.17B
Total Assets Q3 2025 · Dec 31, 2024 $37.76B
Eps Diluted Q3 2025 · Sep 30, 2025 $13.62
Eps Diluted Q3 2025 · Sep 30, 2025 $33.61
Eps Diluted Q3 2025 · Sep 30, 2024 $11.54
Eps Diluted Q3 2025 · Sep 30, 2024 $30.23
Eps Basic Q3 2025 · Sep 30, 2025 $14.09
Eps Basic Q3 2025 · Sep 30, 2025 $34.83
Eps Basic Q3 2025 · Sep 30, 2024 $12.40
Eps Basic Q3 2025 · Sep 30, 2024 $32.36
Sga Expense Q3 2025 · Sep 30, 2025 $657.8M
Sga Expense Q3 2025 · Sep 30, 2025 $1.93B
Sga Expense Q3 2025 · Sep 30, 2024 $714.4M
Sga Expense Q3 2025 · Sep 30, 2024 $2.16B
Rd Expense Q3 2025 · Sep 30, 2025 $1.48B
Rd Expense Q3 2025 · Sep 30, 2025 $4.22B
Rd Expense Q3 2025 · Sep 30, 2024 $1.27B
Rd Expense Q3 2025 · Sep 30, 2024 $3.72B
Net Income Q3 2025 · Sep 30, 2025 $1.46B
Net Income Q3 2025 · Sep 30, 2025 $3.66B
Net Income Q3 2025 · Jun 30, 2025 $1.39B
Net Income Q3 2025 · Mar 31, 2025 $808.7M
Net Income Q3 2025 · Sep 30, 2024 $1.34B
Net Income Q3 2025 · Sep 30, 2024 $3.49B
Net Income Q3 2025 · Jun 30, 2024 $1.43B
Net Income Q3 2025 · Mar 31, 2024 $722M
Operating Income Q3 2025 · Sep 30, 2025 $1.03B
Operating Income Q3 2025 · Sep 30, 2025 $2.7B
Operating Income Q3 2025 · Sep 30, 2024 $1.18B
Operating Income Q3 2025 · Sep 30, 2024 $3B
Revenue Q3 2025 · Sep 30, 2025 $3.75B
Revenue Q3 2025 · Sep 30, 2025 $10.46B
Revenue Q3 2025 · Sep 30, 2024 $3.72B
Revenue Q3 2025 · Sep 30, 2024 $10.41B